logo

ATR

Aptargroup·NYSE
--
--(--)
--
--(--)
Signals Analysis
Bullish signal 6
Bearish signal 0
Dividend Aristocrat
Consensus Rating "Buy"
Ample Liquidity
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About ATR

Aptargroup, Inc.

A global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services

Containers and Packaging
--
04/23/1993
New York Stock Exchange
14,000
12-31
Common stock
265 Exchange Drive, Suite 301, Crystal Lake, IL 60014
--
Aptargroup, Inc., was incorporated in Delaware in 1992. The company is a global leader in the design and manufacture of drug delivery, dispensing and protection technologies serving the pharmaceutical, fragrance, beauty, food, beverage and personal care markets. Its product portfolio includes distribution pumps, bottle caps, aerosol valves, elastomer components, active material science solutions and digital health technology, serving approximately 5,000 customers worldwide.

Company Financials

EPS

ATR has released its 2025 Q4 earnings. EPS was reported at 1.25, versus the expected 1.23, beating expectations. The chart below visualizes how ATR has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

ATR has released its 2025 Q4 earnings report, with revenue of 962.74M, reflecting a YoY change of 13.52%, and net profit of 74.27M, showing a YoY change of -26.37%. The Sankey diagram below clearly presents ATR's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime

No Data